Episode #1 Future of AI In Drug Development- Guest Malai Sankarasubbar from Saama Technologies
29 mag 2018 ·
20 min. 9 sec.
![Episode #1 Future of AI In Drug Development- Guest Malai Sankarasubbar from Saama Technologies](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/264e7a89d4ccc0f9f7cfe3341885ffaa.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
QCR Global Group is a niche life science management consulting firm, hosting thought leaders on an array of topics in industry. With a primary mission of providing enlightened academic exchange...
mostra di più
QCR Global Group is a niche life science management consulting firm, hosting thought leaders on an array of topics in industry. With a primary mission of providing enlightened academic exchange with change innovators to maximize the cross professional understanding of methods while improving the exchange of information that benefits industry experts and their consumers. Hosted by Dr. D. Orozco, President of the Life Science Practice and Principal Manager at QCR, each thought leader provides a quick explanation of what he/she specializes in, challenges and benefits based on case representation, along with insightful strategies from their angle of the profession.
In our premier episode we discuss the Future of AI in Drug Development with our guest, Malai Sankarasubbar. Mr. Sankarasubbar is the VP of AI at Saama Technologies, a global life science data analytics company.
mostra meno
In our premier episode we discuss the Future of AI in Drug Development with our guest, Malai Sankarasubbar. Mr. Sankarasubbar is the VP of AI at Saama Technologies, a global life science data analytics company.
Informazioni
Autore | QCR GLOBAL GROUP |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company